MedElevator Войти в исследования
← Поиск публикаций

DOI 10.14218/jcth.2024.00237

Медицинская библиотека · Journal of clinical and translational hepatology · 2024

Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study.

Chen Yue, Gao Wenkang, Chu Huikuan, Al-Asbahi Afnan Ahmed Mohamed, Yan Shengqi, Yuan Hang, Che Jiake, Cheng Zilu, Li Zexuan, Ye Jin, Lin Rong, Hou Xiaohua, Du Fan, Yang Ling

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND AIMS: The effect of tenofovir amibufenamide (TMF) on blood lipid profiles in patients with chronic hepatitis B (CHB) remains unclear. This study aimed to explore whether TMF affects blood lipids during 48 weeks in patients with CHB.

METHODS

A total of 91 patients with CHB undergoing TMF treatment for 48 weeks were divided into two groups: Lipid Normal (n = 42) and Lipid Abnormal (n = 49), based on baseline blood lipid levels. Lipid indices, virological responses, and biochemical indicators were compared between the two groups. Clinical observations were further verified through in vitro experiments.

RESULTS

After an average follow-up of 373 ± 121 days, lipid indices in all 91 patients had not significantly changed compared with baseline (total cholesterol: 4.67 vs. 4.69 mmol/L, P = 0.2499; triglycerides: 1.08 vs. 1.04 mmol/L, P = 0.4457; high-density lipoprotein cholesterol: 1.25 vs. 1.25 mmol/L, P = 0.3063; low-density lipoprotein cholesterol: 3.03 vs. 3.02 mmol/L, P = 0.5765). Subgroup comparisons showed lipid indices remained stable. Among treatment-naïve patients (n = 82), complete viral suppression rates were 23.2%, 59.8%, 70.7%, and 86.6% at four, 12, 24, and 48 weeks, respectively. Cellular experiments revealed that TMF did not promote lipid metabolism in primary hepatocytes and AML12 cells.

CONCLUSIONS

Regardless of baseline blood lipid characteristics, 48 weeks of antiviral treatment with TMF in patients with CHB had no significant lipid-raising effect.

Для цитирования: Chen Yue, Gao Wenkang, Chu Huikuan, Al-Asbahi Afnan Ahmed Mohamed, Yan Shengqi, Yuan Hang, Che Jiake, Cheng Zilu, Li Zexuan, Ye Jin, Lin Rong, Hou Xiaohua, Du Fan, Yang Ling. Anti-hepatitis B Virus Treatment with Tenofovir Amibufenamide Has No Impact on Blood Lipids: A Real-world, Prospective, 48-week Follow-up Study.. Journal of clinical and translational hepatology. 2024. DOI: 10.14218/jcth.2024.00237.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.